In late December 2019, severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-
2) was discovered following a cluster of pneumonia cases in Wuhan, China. During the early …

Introduction The multiorgan impact of moderate to severe coronavirus infections in the post-
acute phase is still poorly understood. We aimed to evaluate the excess burden of …

Background: Data regarding the risk of ischemic stroke within 1 year after the post-acute
phase of COVID-19 remain scant. We assess the risk of ischemic stroke in COVID-19 …

Background Although coronavirus disease 2019 (COVID-19) patients who develop in-
hospital acute kidney injury (AKI) have worse short-term outcomes, their long-term outcomes …

Background In electronic health records, patterns of missing laboratory test results could
capture patients' course of disease as well as​​ reflect clinician's concerns or worries for …

Globally, there are an estimated 13.3 million cases of acute kidney injury (AKI) annually.
Although infections are a common cause of AKI globally, most infection-associated AKI …

In addition to its pulmonary effects, coronavirus disease 2019 (COVID-19) has also been
found to cause acute kidney injury (AKI), which has been linked to high mortality rates. In this …

Millions of people worldwide have chronic kidney disease (CKD). Affected patients are at
high risk for cardiovascular (CV) disease for several reasons. Among various comorbidities …

Renal involvement and kidney injury are common in COVID-19 patients, and the symptoms
are more severe if the patient already has renal impairment. Renal involvement in COVID-19 …

Highlights●Infectious SARS-CoV-2 is detectable in kidney tissue in vivo.●Kidney damage
occurs through direct and indirect mechanisms.●Therapy approaches of renal injury …